2[1]MOOLENAAR W H.Lysophosphatidic acid,a multifunctional phospholipids messenger[J].Biol Chem,1995,270(22):12 949-12 952.
3[5]SIESS W.Athero and thrombogenic actions of lysophosphatidic acid and sphingosine-l-phosphate[J].Biochim Biophys Acta,2002,1 582:204-215.
4[7]FOURCADE O,SIMON M F,LITT L,et al.Propofol inhibits human platelet aggregation induced by proinflammatory lipid mediators[J].Anesth Analg,2004,99(2):393-398.
5[8]SIESS W,ZANGL K J,ESSLER M,et al.Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesions[J].Proc Natl Acad Sci USA,1999,96:6 931-6 946.
6[9]ROTHER E,BRANDL R,BAKER D L,et al.Subtypeselectiv antagonists of lysophosphatidic acid receptors inhibit plaelet activation triggered by the lipid core of atherosclerotic plaques[J].Circulation,2003,108:741-747.
7[10]GUEGUEN G,GAIGE B,GREVY J M,et al.Structure-activity analysis of the effects of lysophosphatidic acid on platelet aggregation[J].Biochemistry,1999,38:8 440-8 450.
